Overview


Laura McLane serves as head of McDermott’s Boston Litigation Practice Group and as co-chair of the Firm’s Health Care Litigation Team.  Laura represents national and international clients in health care, securities and other government enforcement matters, both civil and criminal.

Show More

Results


  • Defends national and global health care providers spanning multiple provider types, including dentistry, dialysis, behavioral health, ambulance services and hospitals, in government investigations and related qui tam FCA litigation; also defends medical device and pharmaceutical manufacturers in government investigations and qui tam litigation
  • Successfully advocated on behalf of numerous clients in persuading prosecutors and enforcement agencies to decline to bring charges or intervene
  • Obtained writ of certiorari from the United States Supreme Court on behalf of a health care provider client in an FCA case, after which the Court unanimously reversed an adverse decision of the court of appeals

Show More

Recognitions


  • The Best Lawyers in America 2019 & 2020, Litigation – Health Care
  • Super Lawyers, Rising Star
  • The Legal 500 United States 2019

Credentials


Education
Boston University School of Law, JD, cum laude, 1999
Emory University, BA, 1996

Admissions
Massachusetts

Show More

Laura McLane

Insights & Events / Media

Healthcare Enforcement Quarterly Roundup / August 15, 2019

Webinar / McDermott Event / August 12, 2019

Healthcare Enforcement Quarterly Roundup / April 25, 2019

Healthcare Enforcement Quarterly Roundup / Q4 2018 | January 2019

Webinar / McDermott Event / January 28, 2019

Webinar / McDermott Event / October 23, 2018

Healthcare Enforcement Quarterly Roundup / Q3 | September 2018

Chicago, Illinois / McDermott Event / September 27, 2018

Healthcare Enforcement Quarterly Roundup / Q2 | July 2018

Webinar / McDermott Event / July 17, 2018

Healthcare Enforcement Quarterly Roundup / Q1 | April 2018

Independence Institute / September 25, 2017

Washington Examiner / May 22, 2017

Bloomberg BNA's Health Care Fraud Report / April 2, 2014

Violations of FDA Safety Regulations Do Not Give Rise to False Claims

Law360 / February 3, 2014

1st Circ. Holds FCA Relator’s Feet To The Rule 9(b) Fire

1

2

3